ACXP
Acurx Pharmaceuticals LLC
NASDAQ: ACXP · HEALTHCARE · BIOTECHNOLOGY
$2.16
+0.00% today
Updated 2026-05-01
Market cap
$5.62M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-5.32
Dividend yield
—
52W range
$1 – $21
Volume
3.8M
Acurx Pharmaceuticals LLC (ACXP) Financial statements
SEC filings — annual and quarterly data.
Profit margin
0.00%
Operating margin
0.00%
ROE
-270.80%
ROA
-87.60%
Debt/equity
—
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2019 | $0.00 | $-5.93M | — | — | — |
| 2020 | $0.00 | $-4.60M | — | — | — |
| 2021 | $0.00 | $-12.68M | — | — | — |
| 2022 | $0.00 | $-12.09M | — | — | — |
| 2023 | $0.00 | $-14.58M | — | — | — |
| 2024 | $0.00 | $-14.10M | — | — | — |
| 2025 | $0.00 | $-7.97M | — | — | — |